Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
I think LLY & NVO have more upside before that begins eating into returns but luckily we also own a decent amount of Roche, so this was a positive development for us
The FDA approved tesamorelin in 2010 under the brand Egrifta for HIV-associated lipodystrophy
They claim it could enhance therapeutic outcomes alongside other peptides or treatments
Mayo Foundation for Medical Education and Research
Tirzepatide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of MTC or with MEN2
US$ 27.55
US$ 27.44
US$ 22.53
US$ 26.87
US$ 21.51
US$ 23.84
US$ 27.55
